Sinovac Biotech, Ltd (SVA)

NASDAQ

$--

(--)

After-Hours

Sinovac Biotech, Ltd (SVA) Live Price Chart

Last updated: ⁦2026-10-23 21:20:40⁩. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.

Summary

Sinovac Biotech, Ltd (SVA) operates in the -- sector and is listed on NASDAQ. The stock is currently priced at --, with a market capitalization of -- and a P/E ratio of --. Over the past 52 weeks, its price has ranged from -- to --. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	--
Open	--
Day's High	--
Day's Low	--
Previous Close	--
Volume	--
Average Volume	--
P/E Ratio	--
52-Week High	--
52-Week Low	--
Dividend Yield	--
Earnings Date	--

Sinovac Biotech, Ltd (SVA) After-Hours Stock Price

Sinovac Biotech, Ltd (SVA) is trading at $-- in after-hours trading as of --, -- from the regular-session close of $--.

After-hours trading shows how investors are pricing SVA after the regular session closes. The current after-hours price is -- the regular-session close, indicating -- after-hours sentiment.

Sinovac Biotech, Ltd (SVA) 7-Day Stock Price Change

Over the past seven days, Sinovac Biotech, Ltd (SVA) moved from $6.49 to $6.47, representing a decline of 0.31% ($0.02).

The stock traded between $6.25 and $6.65 during the period. The latest price is near the middle of the 7-day range, indicating range-bound.

The average daily volume was 12.39 thousand shares, up versus the previous seven-day period, indicating higher trading activity.

What is Sinovac Biotech, Ltd (SVA)?

Sinovac Biotech Ltd is a fully integrated China-based biopharmaceutical company focused on the research, development, manufacturing and commercialization of vaccines for the prevention of human infectious diseases, including certain diseases with unmet medical needs. It has developed a comprehensive vaccine portfolio covering hepatitis A, hepatitis B, hand, foot and mouth disease ("HFMD") caused by enterovirus 71 ("EV71"), seasonal and pandemic influenza, COVID-19, pneumococcal disease, poliomyelitis, mumps, varicella, rabies and tetanus. The Company operates exclusively in the research, development, manufacture, and commercialization of vaccines sector. The Company's business is considered as operating in one segment. It has presence in Chinese Mainland, and Outside Chinese Mainland.

Sinovac Biotech, Ltd Information

Employees	2602
Exchange	NASDAQ
Company Website	http://www.sinovac.com

How to Buy Sinovac Biotech, Ltd (SVA) Stock on MEXC

Eligible investors can buy real shares of Sinovac Biotech, Ltd (SVA) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for SVA and Place Your Order

Open the RealStocks trading page and search for SVA. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Sinovac Biotech, Ltd (SVA) stock price today?

Sinovac Biotech, Ltd (SVA) is currently trading at --, -- from the previous close of --. Intraday prices update in real time during regular trading hours.

2.Is SVA stock going up or down today?

As of --, SVA is trading at --, -- from its previous close of --. The stock has traded between -- and -- during today’s regular session. Past price movements do not guarantee future results.

3.What is SVA pre-market price?

As of --, SVA is trading at -- in pre-market trading, -- from the previous close of --. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is SVA after-hours price?

As of --, SVA is trading at -- in after-hours trading, -- from the regular-session close of --. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is SVA stock trading now?

SVA trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does SVA sit relative to its 52-week high and low?

Over the past 52 weeks, SVA has traded between a low of -- and a high of --. At --, the stock is positioned --% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Sinovac Biotech, Ltd in?

Sinovac Biotech, Ltd (SVA) operates in the -- sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Sinovac Biotech, Ltd's market capitalization and where is it listed?

Sinovac Biotech, Ltd is listed on the NASDAQ exchange with a market capitalization of --. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is SVA valued in terms of P/E ratio and EPS?

SVA trades at a P/E ratio of --, based on trailing-twelve-month EPS of --. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Sinovac Biotech, Ltd pay a dividend?

Sinovac Biotech, Ltd pays an indicated annual cash dividend of -- per share, with a current dividend yield of --% based on the latest share price. Dividend policies are subject to change at the board's discretion.